Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 3
2005 1
2010 1
2011 1
2012 2
2013 2
2014 3
2015 1
2016 1
2017 2
2018 1
2019 1
2020 1
2021 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Results by year

Filters applied: . Clear all
Page 1
Interventions for the management of oral ulcers in Behçet's disease.
Taylor J, Glenny AM, Walsh T, Brocklehurst P, Riley P, Gorodkin R, Pemberton MN. Taylor J, et al. Among authors: gorodkin r. Cochrane Database Syst Rev. 2014 Sep 25;2014(9):CD011018. doi: 10.1002/14651858.CD011018.pub2. Cochrane Database Syst Rev. 2014. PMID: 25254615 Free PMC article. Review.
Biologic therapy for Behçet's uveitis: a systematic review.
Uke P, Gorodkin R, Beare N. Uke P, et al. Among authors: gorodkin r. Br J Ophthalmol. 2020 Aug;104(8):1045-1051. doi: 10.1136/bjophthalmol-2019-314154. Epub 2019 Nov 1. Br J Ophthalmol. 2020. PMID: 31676596
Behcet's disease and refractory thrombosis.
Thorell SE, Gorodkin R, Murray D, Thachil J. Thorell SE, et al. Among authors: gorodkin r. QJM. 2015 Jun;108(6):489-90. doi: 10.1093/qjmed/hcu141. Epub 2014 Jun 30. QJM. 2015. PMID: 24982203 No abstract available.
Possible therapeutic use of vasodilator iontophoresis.
Murray AK, Herrick AL, Gorodkin RE, Moore TL, King TA. Murray AK, et al. Among authors: gorodkin re. Microvasc Res. 2005 Jan;69(1-2):89-94. doi: 10.1016/j.mvr.2005.01.005. Microvasc Res. 2005. PMID: 15797265
BSR and BHPR guideline for the prescription and monitoring of non-biologic disease-modifying anti-rheumatic drugs.
Ledingham J, Gullick N, Irving K, Gorodkin R, Aris M, Burke J, Gordon P, Christidis D, Galloway S, Hayes E, Jeffries A, Mercer S, Mooney J, van Leuven S, Galloway J; BSR and BHPR Standards, Guidelines and Audit Working Group. Ledingham J, et al. Among authors: gorodkin r. Rheumatology (Oxford). 2017 Jun 1;56(6):865-868. doi: 10.1093/rheumatology/kew479. Rheumatology (Oxford). 2017. PMID: 28339817 No abstract available.
BSR and BHPR guideline for the prescription and monitoring of non-biologic disease-modifying anti-rheumatic drugs.
Ledingham J, Gullick N, Irving K, Gorodkin R, Aris M, Burke J, Gordon P, Christidis D, Galloway S, Hayes E, Jeffries A, Mercer S, Mooney J, van Leuven S, Galloway J. Ledingham J, et al. Among authors: gorodkin r. Rheumatology (Oxford). 2017 Dec 1;56(12):2257. doi: 10.1093/rheumatology/kex389. Rheumatology (Oxford). 2017. PMID: 29029272 No abstract available.
17 results